Meeting
2021 Genitourinary Cancers Symposium
The role of androgen deprivation therapy on the clinical course of COVID-19 infection in men with prostate cancer.
Authors
Vaibhav G. Patel
Tisch Cancer Institute, Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
Vaibhav G. Patel , Xiaobo Zhong , Neil J. Shah , Luis Pina Martina , Jessica Hawley , Emily Lin , Benjamin Adam Gartrell , Victor Ricardo Adorno Febles , David R Wise , Qian Qin , George Mellgard , Jones T. Nauseef , David Green , Panagiotis J. Vlachostergios , Daniel Kwon , Franklin W. Huang , Bobby Chi-Hung Liaw , Scott T. Tagawa , Michael J. Morris , William K. Oh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Advanced Disease
Track
Prostate Cancer - Advanced
Sub Track
Impact of COVID-19
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 41)
DOI
10.1200/JCO.2021.39.6_suppl.41
Abstract #
41
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
Severe-COVID-19 and mortality among patients (pts) with prostate cancer (PCa) receiving androgen deprivation therapy (ADT).
First Author: Matthew D Tucker
Poster
2021 Genitourinary Cancers Symposium
Androgen deprivation therapy and risk of SARS-CoV-2 infection in men with prostate cancer: A University of California (UC) Health System registry study.
First Author: Daniel Kwon
Poster
2022 ASCO Genitourinary Cancers Symposium
Effect of androgen receptor directed therapy in prostate cancer patients with COVID-19.
First Author: Serhan Unlu
Poster
2018 Genitourinary Cancers Symposium
Medical resource utilization (MRU) of abiraterone acetate plus prednisone (AAP) added to androgen deprivation therapy (ADT) in metastatic castration-naive prostate cancer: Results from LATITUDE.
First Author: Tracy Li